GSK expects shingles drug sales to exceed $1.3 billion Garima2 May 2019 9:00 AM ISTFTSE-100 member GSK, whose shares were up 0.3 per cent to 1,580 pence at 1156 GMT, also said it had decided to stop the clinical development of its...